An Nf-Kb-Regulated Micro-Rna-146a-Mediated Inflammatory Circuit In Alzheimer'S Disease Brain

walter j lukiw,jianguo cui,yuhai zhao

DOI: https://doi.org/10.1096/fasebj.23.1_supplement.665.2

2009-01-01

Abstract:Human brains utilize discrete populations of micro RNA (miRNA) that normally support homeostatic brain gene expression functions. The abundance of these miRNAs are significantly altered in neurological disorders such as Alzheimer's disease when compared to age‐matched controls. Here we provide evidence in Alzheimer's disease brains of a specific up‐regulation of an NF‐kB‐sensitive miRNA‐146a highly complementary to the 3' un‐translated region (3'UTR) of complement factor H (CFH), an important repressor of the brain's inflammatory response. Up‐regulation of miRNA‐146a coupled to down‐regulation of CFH was observed in both Alzheimer's disease brain and in IL‐1β, Aβ42 and/or oxidatively‐stressed human neural cells in primary culture. Transfection experiments using an NF‐kB‐containing pre‐miRNA‐146a promoter‐luciferase reporter construct in stressed human neural cells showed significant up‐regulation of luciferase activity that paralleled decreases in CFH gene expression. Parallel treatment of these stressed cells with the NF‐kB inhibitors pyrollidine dithiocarbamate (PDTC) or the resveratrol analog CAY10512 abrogated this response. Incubation of an antisense oligonucleotide to miRNA‐146a (anti‐miRNA‐146a; AM146a) was found to restore CFH expression levels. These data indicate that NF‐kB‐sensitive miRNA‐146a‐mediated modulation of CFH gene expression may in part regulate an inflammatory response in Alzheimer's disease brain and in cultured cell models of AD, and underscores the potential for anti‐miRNAs as an effective therapeutic strategy against pathogenic inflammatory signaling.